BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20665716)

  • 1. The possibility of microarray-based analysis using cell-free placental mRNA in maternal plasma.
    Miura K; Miura S; Yamasaki K; Shimada T; Kinoshita A; Niikawa N; Yoshiura K; Masuzaki H
    Prenat Diagn; 2010 Sep; 30(9):849-61. PubMed ID: 20665716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma mRNAs of placenta-specific 1 (PLAC1) and glial cells-missing 1 (GCM1) in mothers with pre-eclampsia.
    Fujito N; Samura O; Miharu N; Tanigawa M; Hyodo M; Kudo Y
    Hiroshima J Med Sci; 2006 Mar; 55(1):9-15. PubMed ID: 16594548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A microarray approach for systematic identification of placental-derived RNA markers in maternal plasma.
    Tsui NB; Lo YM
    Methods Mol Biol; 2008; 444():275-89. PubMed ID: 18425489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placenta-derived, cellular messenger RNA expression in the maternal blood of preeclamptic women.
    Okazaki S; Sekizawa A; Purwosunu Y; Farina A; Wibowo N; Okai T
    Obstet Gynecol; 2007 Nov; 110(5):1130-6. PubMed ID: 17978129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine-related genes and oxidation-related genes detected in preeclamptic placentas.
    Lee GS; Joe YS; Kim SJ; Shin JC
    Arch Gynecol Obstet; 2010 Oct; 282(4):363-9. PubMed ID: 19787364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of circulating placental mRNA in maternal blood of pregnancies affected with fetal congenital heart diseases at the second trimester of pregnancy: implications for early molecular screening.
    Arcelli D; Farina A; Cappuzzello C; Bresin A; De Sanctis P; Perolo A; Prandstraller D; Valentini D; Zucchini C; Priori S; Rizzo N
    Prenat Diagn; 2010 Mar; 30(3):229-34. PubMed ID: 20063376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls.
    Farina A; Sekizawa A; Purwosunu Y; Rizzo N; Banzola I; Concu M; Morano D; Giommi F; Bevini M; Mabrook M; Carinci P; Okai T
    Prenat Diagn; 2006 Dec; 26(12):1115-20. PubMed ID: 16952198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative profiling of metabolism-related gene expression in pre-eclamptic and normal pregnancies.
    Pang ZJ; Xing FQ
    Arch Gynecol Obstet; 2004 Jan; 269(2):91-5. PubMed ID: 14648175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomewide oligonucleotide microarray analysis on placentae of pre-eclamptic pregnancies.
    Zhou R; Zhu Q; Wang Y; Ren Y; Zhang L; Zhou Y
    Gynecol Obstet Invest; 2006; 62(2):108-14. PubMed ID: 16651850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calreticulin in human pregnancy and pre-eclampsia.
    Gu VY; Wong MH; Stevenson JL; Crawford KE; Brennecke SP; Gude NM
    Mol Hum Reprod; 2008 May; 14(5):309-15. PubMed ID: 18417548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarray screening for novel preeclampsia biomarker candidates.
    Lapaire O; Grill S; Lalevee S; Kolla V; Hösli I; Hahn S
    Fetal Diagn Ther; 2012; 31(3):147-53. PubMed ID: 22472943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of labour and placental separation on the shedding of syncytiotrophoblast microparticles, cell-free DNA and mRNA in normal pregnancy and pre-eclampsia.
    Reddy A; Zhong XY; Rusterholz C; Hahn S; Holzgreve W; Redman CW; Sargent IL
    Placenta; 2008 Nov; 29(11):942-9. PubMed ID: 18834630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of physiological alterations of the placenta through analysis of cell-free messenger ribonucleic acid concentrations of angiogenic factors.
    Purwosunu Y; Sekizawa A; Farina A; Wibowo N; Koide K; Okazaki S; Nakamura M; Okai T
    Am J Obstet Gynecol; 2008 Jan; 198(1):124.e1-7. PubMed ID: 18166325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia.
    Nishizawa H; Pryor-Koishi K; Kato T; Kowa H; Kurahashi H; Udagawa Y
    Placenta; 2007; 28(5-6):487-97. PubMed ID: 16860862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel biomarkers in preeclampsia.
    Smets EM; Visser A; Go AT; van Vugt JM; Oudejans CB
    Clin Chim Acta; 2006 Feb; 364(1-2):22-32. PubMed ID: 16139262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling of placentas affected by pre-eclampsia.
    Hoegh AM; Borup R; Nielsen FC; Sørensen S; Hviid TV
    J Biomed Biotechnol; 2010; 2010():787545. PubMed ID: 20204130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of angiogenesis-related placental genes in pre-eclampsia associated with intrauterine growth restriction.
    Jarvenpaa J; Vuoristo JT; Savolainen ER; Ukkola O; Vaskivuo T; Ryynanen M
    Gynecol Endocrinol; 2007 Jun; 23(6):351-5. PubMed ID: 17616861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mRNA of placental origin is readily detectable in maternal plasma.
    Ng EK; Tsui NB; Lau TK; Leung TN; Chiu RW; Panesar NS; Lit LC; Chan KW; Lo YM
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4748-53. PubMed ID: 12644709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma factors in severe early-onset preeclampsia do not substantially alter endothelial gene expression in vitro.
    Donker RB; Asgeirsdóttir SA; Gerbens F; van Pampus MG; Kallenberg CG; te Meerman GJ; Aarnoudse JG; Molema G
    J Soc Gynecol Investig; 2005 Feb; 12(2):98-106. PubMed ID: 15695104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary study of DNA microarray of human placenta gene expression profile.
    Zhu LN; Ma WL; Mao XM; Li L; Feng CQ; Zheng WL
    Di Yi Jun Yi Da Xue Xue Bao; 2002 May; 22(5):400-2. PubMed ID: 12390695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.